VIR - Vir Biotechnology announces transition of chief scientific officer
- Vir Biotechnology ( NASDAQ: VIR ) announced that Herbert “Skip” Virgin, M.D., Ph.D., executiveVP, research and chief scientific officer, will step down effective August 31, 2022.
- He will pursue a new position as chief medical officer and head of the Altos Institute of Medicine.
- HePhil Pang, M.D., Ph.D., Vir’s executive VP and chief medical officer, will take on overall responsibility for research and development on an interim basis while the company identifies a permanent successor.
For further details see:
Vir Biotechnology announces transition of chief scientific officer